Evolus, Inc. (EOLS) vs Tilray Brands, Inc. (TLRY)
- Evolus, Inc. EOLS 7.10 −6.21%
- Tilray Brands, Inc. TLRY 3.04 −5.30%
Evolus, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. and Tilray Brands, Inc. are of similar size ($500.0M and $474.4M). Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 13.9%. Evolus, Inc. has the higher net margin (−10.9% vs −17.1%) and the lower return on invested capital (−14.5% vs −3.21%). Across the 17 metrics below, Evolus, Inc. leads on 10 and Tilray Brands, Inc. on 7.
Valuation
Profitability
| Metric | EOLS | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.74% | 29.12% | 53.94% |
| Operating margin | (5.90%) | (9.26%) | 0.00% |
| Net margin | (10.85%) | (17.05%) | 0.00% |
| Free cash flow margin | (6.92%) | (18.11%) | 0.00% |
| Return on equity | 138.57% | (10.50%) | (0.40%) |
| Return on assets | (14.40%) | (7.45%) | (3.32%) |
| Return on invested capital | (14.47%) | (3.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack